Abstract
We have previously reported that activated rac (V12rac) can bring about hypertransformation of ras-transformed epithelial cells, which can be suppressed by the dominant negative form of rac (N17rac). Starting with primary epithelial cells, a series of cell lines expressing wild type (WT) or mutated forms of ras or rac were generated and analysed for their adhesive function and expression and association of adherens junction (AJ) proteins. Normal, primary epithelial cells were self-adhesive and expressed AJs that were very stable. The expression of constitutively active ras resulted in a decrease in, but not loss of, cell-cell adhesion, with concomitantly decreased stability of AJ components. This was extremely exacerbated by the co-expression of constitutively activate rac, but was suppressed by dominant negative rac, which resulted in increased cell-cell adhesion and extremely stable AJs. α-catenin also failed to associate with E-cadherin-β-catenin complexes in cells expressing V12rac. Expression of V12rac resulted in the loss of epithelial morphology. The extent of transformation of each cell type corresponded to the stability of the respective AJ complexes. Thus, rac seems to be involved in regulating the stability of AJs, which promote epithelial cell differentiation, and consequently, modulating tumor progression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aberle H, Schwartz H and Kemler R. . 1996 J. Cell. Biochem. 61: 514–523.
Barth AI, Nathke IS and Nelson WJ. . 1997 Curr. Opin. Cell Biol. 9: 683–690.
Ben-Ze'ev A. . 1997 Curr. Opin. Cell Biol. 9: 99–108.
Ben-Ze'ev A and Geiger B. . 1998 Curr. Opin. Cell Biol. 10: 629–639.
Birchmeier W and Behrens J. . 1994 Biochim. Biophys. Acta 1198: 11–26.
Birchmeier W, Behrens J, Weidner KM, Hulsken J and Birchmeier C. . 1996 Curr. Top. Microbiol. Immunol. 213: 117–135.
Birchmeier W, Hulsken J and Behrens J. . 1995 Cancer Surveys 24: 129–140.
Braga VM, Machesky LM, Hall A and Hotchin NA. . 1997 J. Cell Biol. 137: 1421–1431.
Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ and Der CJ. . 1998 Oncogene 17: 1395–1413.
del Peso L, Hernandez-Alcoceba R, Embade N, Crnero AEP, Paje C and Lacal JC. . 1997 Oncogene 15: 3047–3057.
Douglas JL, Gopalakrishnan S and Quinlan MP. . 1991 Oncogene 6: 2093–2103.
Eaton S, Auvinen P, Luo L, Jan YN and Simons K. . 1995 J. Cell Biol. 131: 151–164.
Fischer RS and Quinlan MP. . 1998a Virology 249: 427–439.
Fischer RS and Quinlan MP. . 1998b Cell Growth Differ. 9: 905–918.
Fischer RS, Zheng Y and Quinlan MP. . 1998 Cell Growth Differ. 9: 209–221.
Frixen U, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D and Birchmeier W. . 1991 J. Cell. Biol. 111: 173–185.
Geiger B, Yehuda-Levenberg S and Bershadsky AD. . 1995 Acta. Anat. 154: 46–62.
Gopalakrishnan S and Quinlan MP. . 1995 Cell Growth Differ. 6: 985–998.
Gumbiner BM. . 1996 Cell 84: 345–357.
Hall A. . 1998 Science 279: 509–513.
Hay ED. . 1995 Acta. Anat. 154: 8–20.
Hay ED and Zuk A. . 1995 Am. J. Kidney Dis. 26: 678–690.
Hinck L, Nathke IS, Papkoff J and Nelson WJ. . 1994 J. Cell. Biol. 125: 1327–1340.
Hirohashi S. . 1998 Am. J. Pathol. 153: 333–339.
Hordijk PL, ten Klooster JP, van der Kammen RA, Michiels F, Oomen LC and Collard JG. . 1997 Science 278: 1464–1466.
Huber O, Bierkamp C and Kemler R. . 1996 Curr. Opin. Cell. Biol. 8: 685–691.
Hunter T. . 1997 Cell 88: 333–346.
Hynes RO. . 1996 Dev. Biol. 180: 402–412.
Jankowski JA, Bruton R, Shepherd N and Sanders DS. . 1997 Mol. Pathol. 50: 289–290.
Janmey PA. . 1998 Physiol. Rev. 78: 763–781.
Joneson T and Bar-Sagi D. . 1997 J. Mol. Med. 75: 587–593.
Joneson T, White MA, Wigler MH and Bar-Sagi D. . 1996 Science 271: 810–812.
Jordan MA and Wilson L. . 1998 Curr. Opin. Cell. Biol. 10: 123–130.
Jou TS and Nelson WJ. . 1998 J. Cell Biol. 142: 85–100.
Keely PJ, Westwick JK, Whitehead IP, Der CJ and Parise LV. . 1997 Nature 390: 632–636.
Khosravi-Far R, Solski PA, Clark GJ, Kinch MS and Der CJ. . 1995 Mol. Cell. Biol. 15: 6443–6453.
Kintner C. . 1992 Cell 69: 225–236.
Kobayashi K, Kuroda S, Fukata M, Nakamura T, Nagase T, Nomura N, Matsuura Y, Yoshida-Kubomura N, Iwamatsu A and Kaibuchi K. . 1998 J. Biol. Chem. 273: 291–295.
Kuroda S, Fukata M, Fujii K, Nakamura T, Izawa I and Kaibuchi K. . 1997 Biochem. Biophys. Res. Commun. 240: 430–435.
Kuroda S, Fukata M, Nagawa M, Fujii K, Nakamura T, Ookubo T, Izawa I, Nagase T, Nomura N, Tani H, Shoji I Matsuura Y, Yonehara S and Kaibuchi K. . 1998 Science 281: 832–835.
Li ZR, Hromchak R, Mudipalli A and Bloch A. . 1998 Cancer Res. 58: 4282–4287.
Macara IG, Lounsbury KM, Richards SA, McKiernan C and Bar-Sagi D. . 1996 FASEB J. 10: 625–630.
Mackay DJ, Esch F, Furthmayr H and Hall A. . 1997 J. Cell Biol. 138: 927–938.
Malumbres M and Pellicer A. . 1998 Front. Biosci. 3: 887–912.
Mareel M, Boterberg T, Noe V, Van Hoorde L, Vermeulen S, Bruyneel E and Bracke M. . 1997 J. Cell Physiol. 173: 271–274.
Mareel M, Bracke M and Van Roy F. . 1995 Cancer Detect. Prev. 19: 451–464.
Marrs JA and Nelson WJ. . 1996 Int. Rev. Cytol. 165: 159–205.
Marshall CJ. . 1996 Curr. Opin. Cell. Biol. 8: 197–204.
Michiels F, Habets GGM, Stam JC, Van der Kammen RA and Collard JG. . 1995 Nature 375: 338–340.
Moll R, Franke WW, Schiller DL, Geiger B and Krepler R. . 1982 Cell 31: 11–24.
Nagafuchi A, Ishihara S and Tsukita S. . 1994 J. Cell Biol. 127: 235–245.
Nathke IS, Hinck L, Swedlow JR, Papkoff J and Nelson WJ. . 1994 J. Cell Biol. 125: 1341–1352.
Nimnual AS, Yatsula BA and Bar-Sagi D. . 1998 Science 279: 560–563.
Ozawa M and Kemler R. . 1998 J. Biol. Chem. 273: 6166–6170.
Perl AK, Wilgenbus P, Dahl U, Semb H and Christofori G. . 1998 Nature 392: 190–193.
Pillay I, Nakano H and Sharma SV. . 1996 Cell Growth Differ. 7: 1487–1499.
Potempa S and Ridley AJ. . 1998 Mol. Biol. Cell. 9: 2185–2200.
Qui R-G, Chen J, Kirn D, McCormick F and Symons M. . 1995 Nature 374: 457–459.
Quinlan MP and Douglas JL. . 1992 J. Virol. 66: 2020–2030.
Quinlan MP, White P and Grodzicker T. . 1988 Mol. Cell. Biol. 8: 3191–3203.
Ridley AJ, Comoglio PM and Hall A. . 1995 Mol. Cell. Biol. 15: 1110–1112.
Ridley AM, Paterson HF, Johnston CL, Diekmann D and Hall A. . 1992 Cell 70: 401–410.
Rimm DL, Koslov ER, Kebriaei P, Cianci CD and Morrow JS. . 1995 Proc. Natl. Acad. Sci. USA 92: 8813–8817.
Roux P, Gauthier RC, Doucet BS and Fort P. . 1997 Curr. Biol. 7: 629–637.
Sander EE, van Delft S, ten Klooster JP, Reid T, van der Kammen RA, Michiels F and Collard JG. . 1998 J. Cell Biol. 143: 1385–1398.
Sasaki T and Takai Y. . 1998 Biochim. Biophys. Res. Commun. 245: 641–645.
Schmidt A and Hall MN. . 1998 Annu. Rev. Cell Dev. Biol. 14: 305–338.
Schoenenberger C and Matlin KS. . 1991 Trends Cell Biol. 1: 87–92.
Shiozaki H, Oka H, Inoue M, Tamura S and Monden M. . 1996 Cancer 77: 1605–1613.
Steinberg MS. . 1996 Dev. Biol. 180: 377–388.
Symons M. . 1996 Trends Biochem. Sci. 21: 178–181.
Takaishi K, Sasaki T, Kotani H, Nishioka H and Takai Y. . 1997 J. Cell Biol. 139: 1047–1059.
Takeichi M. . 1995 Curr. Opin. Cell Biol. 7: 619–627.
Tanaka K and Takai Y. . 1998 Curr. Opin. Cell Biol. 10: 112–116.
Tapon N and Hall A. . 1997 Curr. Opin. Cell Biol. 9: 86–92.
Tsukatani Y, Suzuki K and Takahashi K. . 1997 J. Cell. Physiol. 173: 54–63.
Van Aelst L and D'Souza-Schorey C. . 1997 Genes Dev. 11: 2295–2322.
Vermeulen S, Van Marck VV, Van Hoorde L, Van Roy F, Bracke M and Mareel M. . 1996 Path. Res. Prac. 192: 694–707.
Wasserman S. . 1998 Trends Cell Biol. 8: 111–115.
Westwick JK, Lambert QT, Clark GJ, Symons M, Van AL, Pestell RG and Der CJ. . 1997 Mol. Cell. Biol. 17: 1324–1335.
Wittinghofer A. . 1998 Biol. Chem. 379: 933–937.
Wojciak-Stothard B, Entwistle A, Garg R and Ridley AJ. . 1998 J. Cell Physiol. 176: 150–165.
Yap AS, Briehr WM and Gumbiner BM. . 1997 Annu. Rev. Cell Dev. Biol. 13: 119–146.
Yonemura S, Itoh M, Nagafuchi A and Tsukita S. . 1995 J. Cell. Sci. 108: 127–142.
Zigmond S. . 1996 Curr. Opin. Cell Biol. 8: 66–73.
Zohn IM, Campbell SL, Khosravi-Far R, Rossman KL and Der CJ. . 1998 Oncogene 17: 1415–1438.
Acknowledgements
L Hendershot is thanked for the grp94 antibody and Y Zheng is thanked for providing the V12rac and N17rac expression vectors. The cell culture assistance of J Hyatt and graphics work of RAL20 are gratefully appreciated. This work was supported by the University of Tennessee (UTRC).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Quinlan, M. Rac regulates the stability of the adherens junction and its components, thus affecting epithelial cell differentiation and transformation. Oncogene 18, 6434–6442 (1999). https://doi.org/10.1038/sj.onc.1203026
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203026
Keywords
This article is cited by
-
Targeting geranylgeranylation reduces adrenal gland tumor burden in a murine model of prostate cancer metastasis
Clinical & Experimental Metastasis (2015)
-
ICAM-2 regulates vascular permeability and N-cadherin localization through ezrin-radixin-moesin (ERM) proteins and Rac-1 signalling
Cell Communication and Signaling (2014)
-
Wnt4 inhibits cell motility induced by oncogenic Ras
Oncogene (2013)
-
RAS oncogenes: weaving a tumorigenic web
Nature Reviews Cancer (2011)
-
Rac1 activation inhibits E-cadherin-mediated adherens junctions via binding to IQGAP1 in pancreatic carcinoma cells
Cell Communication and Signaling (2009)